Literature DB >> 16643317

Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early-onset Parkinson's Disease.

J M Hertz1, K Ostergaard, I Juncker, S Pedersen, A Romstad, L B Møller, F Güttler, E Dupont.   

Abstract

Autosomal recessive Parkinson's disease (PD) with early-onset may be caused by mutations in the parkin gene (PARK2). We have ascertained 87 Danish patients with an early-onset form of PD (age at onset < or =40 years, or < or =50 years if family history is positive) in a multicenter study in order to determine the frequency of PARK2 mutations. Analysis of the GTP cyclohydrolase I gene (GCH1) and the tyrosine hydroxylase gene (TH), mutated in dopa-responsive dystonia and juvenile PD, have also been included. Ten different PARK2 mutations were identified in 10 patients. Two of the patients (2.3%) were found to have homozygous or compound heterozygous mutations, and eight of the patients (9.2%) were found to be heterozygous. A mutation has been identified in 10.4% of the sporadic cases and in 15.0% of cases with a positive family history of PD. One patient was found to be heterozygous for both a PARK2 mutation and a missense mutation (A6T) in TH of unknown significance. It cannot be excluded that both mutations contribute to the phenotype. No other putative disease causing TH or GCH1 mutations were found. In conclusion, homozygous, or compound heterozygous PARK2 mutations, and mutations in GCH1 and TH, are rare even in a population of PD patients with early-onset of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16643317     DOI: 10.1111/j.1468-1331.2006.01249.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  14 in total

1.  Parkinsonism in GTP cyclohydrolase 1 mutation carriers.

Authors:  Ilaria Guella; Holly E Sherman; Silke Appel-Cresswell; Alex Rajput; Ali H Rajput; Matthew J Farrer
Journal:  Brain       Date:  2014-12-13       Impact factor: 13.501

2.  Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study.

Authors:  R N Alcalay; A Siderowf; R Ottman; E Caccappolo; H Mejia-Santana; M-X Tang; L Rosado; E Louis; D Ruiz; C Waters; S Fahn; L Cote; S Frucht; B Ford; M Orbe-Reilly; B Ross; M Verbitsky; S Kisselev; C Comella; A Colcher; D Jennings; M Nance; S Bressman; W K Scott; C Tanner; S Mickel; M Rezak; K E Novak; J H Friedman; R Pfeiffer; L Marsh; B Hiner; L N Clark; K Marder
Journal:  Neurology       Date:  2010-12-29       Impact factor: 9.910

Review 3.  Twenty years since the discovery of the parkin gene.

Authors:  Nobutaka Hattori; Yoshikuni Mizuno
Journal:  J Neural Transm (Vienna)       Date:  2017-06-15       Impact factor: 3.575

4.  Common and rare GCH1 variants are associated with Parkinson's disease.

Authors:  Uladzislau Rudakou; Bouchra Ouled Amar Bencheikh; Jennifer A Ruskey; Lynne Krohn; Sandra B Laurent; Dan Spiegelman; Christopher Liong; Stanley Fahn; Cheryl Waters; Oury Monchi; Edward A Fon; Yves Dauvilliers; Roy N Alcalay; Nicolas Dupré; Ziv Gan-Or
Journal:  Neurobiol Aging       Date:  2018-09-15       Impact factor: 4.673

5.  Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.

Authors:  Karen S Marder; Ming X Tang; Helen Mejia-Santana; Llency Rosado; Elan D Louis; Cynthia L Comella; Amy Colcher; Andrew D Siderowf; Danna Jennings; Martha A Nance; Susan Bressman; William K Scott; Caroline M Tanner; Susan F Mickel; Howard F Andrews; Cheryl Waters; Stanley Fahn; Barbara M Ross; Lucien J Cote; Steven Frucht; Blair Ford; Roy N Alcalay; Michael Rezak; Kevin Novak; Joseph H Friedman; Ronald F Pfeiffer; Laura Marsh; Brad Hiner; Gregory D Neils; Miguel Verbitsky; Sergey Kisselev; Elise Caccappolo; Ruth Ottman; Lorraine N Clark
Journal:  Arch Neurol       Date:  2010-06

6.  Evaluation of PARKIN gene variants in West Bengal Parkinson's disease patients.

Authors:  Jaya Sanyal; Arpita Jana; Epsita Ghosh; Tapas K Banerjee; Durga P Chakraborty; Vadlamudi R Rao
Journal:  J Hum Genet       Date:  2015-05-28       Impact factor: 3.172

7.  Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and control.

Authors:  J Brooks; J Ding; J Simon-Sanchez; C Paisan-Ruiz; A B Singleton; S W Scholz
Journal:  J Med Genet       Date:  2009-04-06       Impact factor: 6.318

8.  The V81M variant of tyrosine hydroxylase is associated with more severe freezing of gait in Parkinson's disease.

Authors:  Izel Tekin; Nurgul Carkaci-Salli; Mechelle M Lewis; Richard B Mailman; Xuemei Huang; Kent E Vrana
Journal:  Parkinsonism Relat Disord       Date:  2015-12-23       Impact factor: 4.891

Review 9.  Tyrosine hydroxylase gene: another piece of the genetic puzzle of Parkinson's disease.

Authors:  Guney Bademci; Jeffery M Vance; Liyong Wang
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-06-01       Impact factor: 4.388

Review 10.  Human tyrosine hydroxylase in Parkinson's disease and in related disorders.

Authors:  Toshiharu Nagatsu; Akira Nakashima; Hiroshi Ichinose; Kazuto Kobayashi
Journal:  J Neural Transm (Vienna)       Date:  2018-07-11       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.